Datavault AI, a company that utilizes artificial intelligence to help individuals understand, value, and monetize their data, has recently announced a significant financial development. They have signed an agreement to receive a strategic investment of $150 million from Scilex Holding Company.
This substantial investment is designed to be completed in two separate parts. The first part, an initial sum of $8,067,000, is anticipated to be finalized on September 26, 2025. The larger second part, amounting to $141,933,000, is expected to follow once they receive approval from their stockholders. The entire transaction is being conducted using Bitcoin at the current market price published by Coinbase.com.
This funding is intended to significantly improve Datavault AI’s financial standing and provide the necessary funds to enhance its robust supercomputing infrastructure, expand its independent data exchanges, and explore new avenues for generating income.
Datavault AI is confident that its unique, patented technology platform is well-positioned to benefit from growth in several key sectors, including biotechnology, natural resources, energy, and entertainment. This optimism is fueled by projections that the global artificial intelligence market will reach an impressive $1.8 trillion by 2030. Furthermore, the market for analytics specifically within the life sciences was estimated to be $35.69 billion in 2024 and is expected to grow steadily at an average annual rate of 11.4% through 2030.
By utilizing advanced technologies like Web 3.0, secure data trading through blockchain, and AI-powered analytics, Datavault AI offers secure and adaptable solutions that address critical issues, including building trust, maintaining data accuracy, and finding effective ways to monetize data. The completion of the second part of Scilex’s investment is dependent on meeting standard conditions, which include getting approval from Datavault AI’s shareholders.
This approval is needed to issue shares to Scilex that might exceed the 19.99% share limitation set by the Nasdaq listing rules. The company plans to seek this approval from its stockholders during its upcoming annual shareholder meeting.
KEY QUOTES:
“Datavault AI’s cutting-edge technologies align perfectly with the biotech sector’s need for advanced data analytics, AI-driven insights, and super computing power. This investment reflects our belief in Datavault’s ability to transform markets where trust and precision are critical. Biotech is a market we know well, and we will help guide Datavault to maximum revenue generation in our sector while they expand across the global economy. With our resources and their patented technology, we see an incredible opportunity to drive real global impact together.”
Henry Ji, Ph.D., CEO and President of Scilex Holding Company
“We believe the investment is particularly significant for biotech, strengthening the company’s high-performance computing capabilities and supporting partnerships with the U.S. Department of Energy’s Brookhaven National Laboratory and IBM WatsonX. By leveraging Web 3.0, blockchain-secured data trading, and AI-driven analytics, Datavault AI aims to deliver secure, scalable solutions addressing trust, data integrity, and monetization challenges. The partnership with Scilex will also support the continued development of previously announced platforms, including the International Elements Exchange, International NIL Exchange, and American Politics Exchange.”
Nathaniel Bradley, CEO of Datavault AI
